# Alzamend Neuro, Inc.: Form 8-K, filed May 15, 2024

- Company: [Alzamend Neuro, Inc.](/companies/alzn.md) (CIK 1677077)
- Form: 8-K
- Filed: 2024-05-15
- Accepted by EDGAR: May 15, 2024, 16:30 ET
- Period: 2024-05-15
- Accession: 0001214659-24-009345
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1677077/000121465924009345/g5152428k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1677077/000121465924009345/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1677077/000121465924009345/g5152428k.htm

Filed May 15, 2024.
Source: SEC EDGAR, the filing index for accession 0001214659-24-009345. Last ingested by Listed: Nov 11, 2026, 01:45 ET. No prices; not investment advice.
